对Fusobacterium nucleatum驱动调节c-Myc途径在口腔癌发生过程中的分析
Charu Priya1, Anshi Jain1, Devi Charan Shetty1
1Department of Oral and Maxillofacial Pathology and Microbiology, ITS Centre for Dental Studies and Research, Ghaziabad, Uttar Pradesh, India.
F1000Research
|March 6, 2026
概括
Fusobacterium nucleatum细菌与口腔潜在恶性疾病 (OPMD) 和口腔平细胞癌 (OSCC) 中的较高c-Myc表达有关. 这表明F. nucleatum可能驱动口腔癌的发展,并可能成为治疗点.
科学领域:
- 口腔病理学 口腔病理学
- 微生物学 微生物学
- 分子生物学分子生物学
背景情况:
- 口腔潜在恶性疾病 (OPMD) 和口腔状细胞癌 (OSCC) 是严重的口腔健康问题.
- 越来越多地认识到特定细菌,如Fusobacterium nucleatum在口腔癌发生中的作用.
研究的目的:
- 调查Fusobacterium nucleatum和c-Myc在OPMD和OSCC中的表达之间的关联.
- 探索F.核在口腔癌进展中的潜在作用.
主要方法:
- 对32例经组织病理学证实病例 (18例OPMD,14例OSCC) 的分析.
- 使用无氧培养和聚合酶链反应 (PCR) 检测F. nucleatum.
- 通过免疫组织化学 (IHC) 评估c-Myc表达.
主要成果:
- 在OPMD和OSCC中检测到F. nucleatum,在OSCC中患病率和殖民地数量更高.
- 所有样本都表达了c-Myc,在OPMD和OSCC之间有不同的水平和局部化模式.
- 具有F. nucleatum阳性的OSCC病例显示出强烈的核c-Myc染色,并且在结合烟草习惯的患者中更为常见.
结论:
- Fusobacterium nucleatum殖民与OPMD和OSCC中c-Myc表达升高相关.
- 这些发现支持F. nucleatum在微生物驱动的口腔癌发生中的作用.
- 在口腔癌中,F. nucleatum显示出作为预后生物标志物和治疗点的潜力.
关键词:
致癌的发生是致癌的产生.杆菌核酸 (Fusobacterium nucleatum) 是一种细菌.口腔微生物组是口腔的微生物组.口腔潜在恶性疾病 (OPMDs)口腔状细胞癌 (OSCC) 是一种c-Myc的表达方式更多相关视频
相关概念视频
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K
Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K


